Last reviewed · How we verify
Placebo eye drop — Competitive Intelligence Brief
marketed
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo eye drop (Placebo eye drop) — Beijing Tongren Hospital. A placebo eye drop produces no pharmacological effect and serves as a control or inert comparator in clinical studies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo eye drop TARGET | Placebo eye drop | Beijing Tongren Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo eye drop CI watch — RSS
- Placebo eye drop CI watch — Atom
- Placebo eye drop CI watch — JSON
- Placebo eye drop alone — RSS
Cite this brief
Drug Landscape (2026). Placebo eye drop — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-eye-drop. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing